Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
Iran J Allergy Asthma Immunol. 2018 Aug 12;17(4):346-360. doi: 10.18502/ijaai.v17i4.94.
Iran J Allergy Asthma Immunol. 2018.
PMID: 30537798
Free article.
Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable patients treated with beta interferon.
Emamnejad R, Sahraian M, Shakiba Y, Salehi Z, Masoomi A, Imani D, Najafi F, Laribi B, Shirzad H, Izad M.
Emamnejad R, et al.
Mult Scler Relat Disord. 2019 Oct;35:233-238. doi: 10.1016/j.msard.2019.08.013. Epub 2019 Aug 12.
Mult Scler Relat Disord. 2019.
PMID: 31421626
Item in Clipboard
Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis.
Imani D, Azimi A, Salehi Z, Rezaei N, Emamnejad R, Sadr M, Izad M.
Imani D, et al. Among authors: emamnejad r.
Int J Immunogenet. 2018 Dec;45(6):329-336. doi: 10.1111/iji.12401. Epub 2018 Sep 28.
Int J Immunogenet. 2018.
PMID: 30264444
Item in Clipboard
Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors.
Emamnejad R, Dass M, Mahlis M, Bozkurt S, Ye S, Pagnin M, Theotokis P, Grigoriadis N, Petratos S.
Emamnejad R, et al.
Front Pharmacol. 2022 Sep 5;13:934971. doi: 10.3389/fphar.2022.934971. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36133808
Free PMC article.
Review.
Item in Clipboard
Cite
Cite